Literature DB >> 24197692

UBE2Q1 expression in human colorectal tumors and cell lines.

Sayed Mohammad Shafiee1, Atefeh Seghatoleslam, Mohsen Nikseresht, Seyed Vahid Hosseini, Mahvash Alizadeh-Naeeni, Akbar Safaei, Ali Akbar Owji.   

Abstract

Colorectal cancer is the third most common cancer in the world. Ubiquitin-proteasome system has shown to be activated in colorectal and other malignancies. UBE2Q1 is a novel human gene that encodes a putative E2 ubiquitin conjugating enzyme. Here, we investigated the expression pattern of UBE2Q1 gene in cell lines and tissues from human colorectal tumors. Quantitative (q) RT-PCR were employed to evaluate the expression levels of the mRNA for UBE2Q1 in colorectal cancer cell lines (HT29/219, LS180, SW742, Caco2, HTC116, SW48, SW480 and SW1116). Expression of UBE2Q1 at the protein levels were assessed by Western blotting in cell lines as well as in 43 human colorectal tumor tissues. All cell lines tested expressed UBE2Q1 gene at the level of both mRNA and protein, with the SW1116 line representing the lowest level of expression. The cell lines HT29/219 and SW742 showed the highest levels of UBE2Q1 protein and mRNA respectively. When compared to corresponding normal tissues, malignant parts of colorectal tumors showed increased levels of UBE2Q1 immunoreactivity in 32 (74.42 %) of cases. These data suggest that UBE2Q1 is differentially expressed in colorectal cell lines and shows overexpression in colorectal tumors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24197692     DOI: 10.1007/s11033-013-2824-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  30 in total

1.  Expression of the novel human gene, UBE2Q1, in breast tumors.

Authors:  Atefeh Seghatoleslam; Mohsen Nikseresht; Sayed Mohammad Shafiee; Ahmad Monabati; Mohammad Mehdi Namavari; Abdolrassul Talei; Akbar Safaei; Ali Akbar Owji
Journal:  Mol Biol Rep       Date:  2011-12-14       Impact factor: 2.316

2.  Expression of UBE2Q2, a putative member of the ubiquitin-conjugating enzyme family in pediatric acute lymphoblastic leukemia.

Authors:  Atefeh Seghatoleslam; Ahmad Monabati; Farzaneh Bozorg-Ghalati; Mohsen Nikseresht; Mohammad-Reza Bordbar; Mostafa Rahvar; Ali Akbar Owji
Journal:  Arch Iran Med       Date:  2012-06       Impact factor: 1.354

3.  Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate.

Authors:  Alexei F Kisselev; Alice Callard; Alfred L Goldberg
Journal:  J Biol Chem       Date:  2006-02-02       Impact factor: 5.157

4.  E2-C, a cyclin-selective ubiquitin carrier protein required for the destruction of mitotic cyclins.

Authors:  A Aristarkhov; E Eytan; A Moghe; A Admon; A Hershko; J V Ruderman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

5.  A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B.

Authors:  R W King; J M Peters; S Tugendreich; M Rolfe; P Hieter; M W Kirschner
Journal:  Cell       Date:  1995-04-21       Impact factor: 41.582

6.  Classification of human colorectal adenocarcinoma cell lines.

Authors:  A Leibovitz; J C Stinson; W B McCombs; C E McCoy; K C Mazur; N D Mabry
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

7.  APC mutations occur early during colorectal tumorigenesis.

Authors:  S M Powell; N Zilz; Y Beazer-Barclay; T M Bryan; S R Hamilton; S N Thibodeau; B Vogelstein; K W Kinzler
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

8.  Differential expression of genes in the endometrium at implantation: upregulation of a novel member of the E2 class of ubiquitin-conjugating enzymes.

Authors:  Michael H Melner; Nicole A Ducharme; Alan R Brash; Virginia P Winfrey; Gary E Olson
Journal:  Biol Reprod       Date:  2003-10-15       Impact factor: 4.285

Review 9.  Ubiquitin ligases in cancer: ushers for degradation.

Authors:  Kim Newton; Domagoj Vucic
Journal:  Cancer Invest       Date:  2007-09       Impact factor: 2.176

Review 10.  Contribution of oncoproteomics to cancer biomarker discovery.

Authors:  William C S Cho
Journal:  Mol Cancer       Date:  2007-04-02       Impact factor: 27.401

View more
  8 in total

1.  Induction of cell proliferation, clonogenicity and cell accumulation in S phase as a consequence of human UBE2Q1 overexpression.

Authors:  Mohammad Ali Fahmidehkar; Sayed Mohammad Shafiee; Ebrahim Eftekhar; Laleh Mahbudi; Atefeh Seghatoleslam
Journal:  Oncol Lett       Date:  2016-07-13       Impact factor: 2.967

2.  Upregulated expression of ubiquitin-conjugating enzyme E2Q1 (UBE2Q1) is associated with enhanced cell proliferation and poor prognosis in human hapatocellular carcinoma.

Authors:  Renan Chang; Lixian Wei; Yuhua Lu; Xiaopeng Cui; Cuihua Lu; Luoliang Liu; Dawei Jiang; YiCheng Xiong; Gang Wang; Chunhua Wan; Haixin Qian
Journal:  J Mol Histol       Date:  2014-10-14       Impact factor: 2.611

3.  Aberrant methylation of UBE2Q1 promoter is associated with poor prognosis of acute-on-chronic hepatitis B pre-liver failure.

Authors:  Na Hu; Xian-Ci Xie; Lin-Lin Liu; Wei-Dong Lai
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

4.  Knockdown of tripartite motif containing 24 by lentivirus suppresses cell growth and induces apoptosis in human colorectal cancer cells.

Authors:  Jianwei Wang; Jinhui Zhu; Mingjun Dong; Hua Yu; Xiaoyu Dai; Keqiang Li
Journal:  Oncol Res       Date:  2014       Impact factor: 5.574

5.  Integrated bioinformatic analysis identifies UBE2Q1 as a potential prognostic marker for high grade serous ovarian cancer.

Authors:  Rachel Topno; Ibha Singh; Manoj Kumar; Pallavi Agarwal
Journal:  BMC Cancer       Date:  2021-03-04       Impact factor: 4.430

Review 6.  The Molecular Basis of Ubiquitin-Conjugating Enzymes (E2s) as a Potential Target for Cancer Therapy.

Authors:  Xiaodi Du; Hongyu Song; Nengxing Shen; Ruiqi Hua; Guangyou Yang
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

7.  LncRNA LINC00525 activates HIF-1α through miR-338-3p / UBE2Q1 / β-catenin axis to regulate the Warburg effect in colorectal cancer.

Authors:  Fanqi Meng; Xiaofan Luo; Chenyao Li; Guangyi Wang
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

8.  UBE2Q1, as a Down Regulated Gene in Pediatric Acute Lymphoblastic Leukemia.

Authors:  Atefeh Seghatoleslam; Farzaneh Bozorg-Ghalati; Ahmad Monabati; Mohsen Nikseresht; Ali Akbar Owji
Journal:  Int J Mol Cell Med       Date:  2014
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.